tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BCRX Stock Latest News

BioCryst reports inducement grants under Nasdaq listing rule
The FlyBioCryst reports inducement grants under Nasdaq listing rule
22d ago
BCRX
BioCryst CFO Anthony Doyle Resigns Effective April 2025
PremiumCompany Announcements
BioCryst CFO Anthony Doyle Resigns Effective April 2025
24d ago
8K
BCRX
BioCryst CFO Anthony Doyle to resign, effective April 9
PremiumThe Fly
BioCryst CFO Anthony Doyle to resign, effective April 9
24d ago
BCRX
BioCryst CFO Anthony Doyle to resign, effective April 9
PremiumThe Fly
BioCryst CFO Anthony Doyle to resign, effective April 9
24d ago
BCRX
BioCryst’s Earnings Call Highlights Strong Growth and Future Prospects
PremiumCompany Announcements
BioCryst’s Earnings Call Highlights Strong Growth and Future Prospects
1M ago
BCRX
BioCryst’s Promising Outlook: Buy Rating Affirmed Amid Strong Sales Guidance and Strategic Growth Initiatives
PremiumRatingsBioCryst’s Promising Outlook: Buy Rating Affirmed Amid Strong Sales Guidance and Strategic Growth Initiatives
1M ago
BCRX
Wedbush bullish on BioCryst, initiates with an Outperform
Premium
The Fly
Wedbush bullish on BioCryst, initiates with an Outperform
1M ago
BCRX
BioCryst initiated with an Outperform at Wedbush
Premium
The Fly
BioCryst initiated with an Outperform at Wedbush
1M ago
BCRX
BioCryst’s Promising Pipeline and Market Position Drive Buy Rating
PremiumRatings
BioCryst’s Promising Pipeline and Market Position Drive Buy Rating
1M ago
BCRX
BioCryst selloff yesterday brings buying opportunity, says JPMorgan
PremiumThe Fly
BioCryst selloff yesterday brings buying opportunity, says JPMorgan
1M ago
BCRX
BioCryst’s Strong Growth Potential and Pipeline Advancements Justify Buy Rating
PremiumRatings
BioCryst’s Strong Growth Potential and Pipeline Advancements Justify Buy Rating
1M ago
BCRX
BioCryst Pharmaceuticals Reports Strong 2024 Revenue Growth
PremiumCompany Announcements
BioCryst Pharmaceuticals Reports Strong 2024 Revenue Growth
1M ago
BCRX
BioCryst’s Growth Prospects: Buy Rating Backed by Revenue Guidance and Pipeline Developments
PremiumRatingsBioCryst’s Growth Prospects: Buy Rating Backed by Revenue Guidance and Pipeline Developments
1M ago
BCRX
BioCryst’s Growth Potential Highlighted by Orladeyo Sales Revision and Pipeline Progress
Premium
Ratings
BioCryst’s Growth Potential Highlighted by Orladeyo Sales Revision and Pipeline Progress
1M ago
BCRX
Apple to invest $500B in U.S., Domino’s reports downbeat Q4: Morning Buzz
Premium
The Fly
Apple to invest $500B in U.S., Domino’s reports downbeat Q4: Morning Buzz
1M ago
OC
APO
BioCryst’s Promising Growth and Market Position: A Buy Recommendation by Stacy Ku
PremiumRatings
BioCryst’s Promising Growth and Market Position: A Buy Recommendation by Stacy Ku
1M ago
BCRX
Morning Movers: Domino’s Pizza slips following quarterly results
PremiumThe Fly
Morning Movers: Domino’s Pizza slips following quarterly results
1M ago
TH
DPZ
BioCryst Faces Patent Challenge Amidst Strong Growth
PremiumCompany Announcements
BioCryst Faces Patent Challenge Amidst Strong Growth
1M ago
8K
BCRX
BioCryst sees FY25 revenue $560M-$575M, consensus $548.9M
PremiumThe Fly
BioCryst sees FY25 revenue $560M-$575M, consensus $548.9M
1M ago
BCRX
BioCryst sees annual CAGR for revenue of around 20% over next three years
PremiumThe FlyBioCryst sees annual CAGR for revenue of around 20% over next three years
1M ago
BCRX
BioCryst reports Q4 EPS (13c), consensus (6c)
Premium
The Fly
BioCryst reports Q4 EPS (13c), consensus (6c)
1M ago
BCRX
BioCryst’s orladeyo shows positive results in angioedema pediatric trial
Premium
The Fly
BioCryst’s orladeyo shows positive results in angioedema pediatric trial
1M ago
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >